Diabetes, Vol 45, Issue 10 1396-1404, Copyright © 1996 by American Diabetes Association

ARTICLES

Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type II diabetic Goto-Kakizaki (GK), obese/aged, and obese/Zucker rats. A mechanism for inhibiting glycogen synthesis

A Avignon, K Yamada, X Zhou, B Spencer, O Cardona, S Saba-Siddique, L Galloway, ML Standaert and RV Farese
J. A. Haley Veterans' Hospital, Tampa, Florida 33612, USA.

We examined the possibility that protein kinase C (PKC) is chronically activated and may contribute to impaired glycogen synthesis and insulin resistance in soleus muscles of hyperinsulinemic type II diabetic Goto-Kakizaki (GK) rats. Relative to nondiabetic controls, PKC enzyme activity and levels of immunoreactive PKC-alpha, beta, epsilon, and delta were increased in membrane fractions and decreased cytosolic fractions of GK soleus muscles. In addition, PKC-theta levels were decreased in both membrane and cytosol fractios, whereas PKC-zeta levels were not changed in either fraction in GK soleus muscles. These increases in membrane PKC (alpha, beta, epsilon, and delta) could not be accounted for by alterations in PKC mRNA or total PKC levels but were associated with increases in membrane diacylglycerol (DAG) and therefore appeared to reflect translocative activation of PKC. In evaluation of potential causes for persistent PKC activation, membrane PKC levels were decreased in soleus muscles of hyperglycemic streptozotocin (STZ)-induced diabetic rats; thus, a role for simple hyperglycemia as a cause of PKC activation in GK rats was not evident in the STZ model. In support of the possibility that hyperinsulinemia contributed to PKC activation in GK soleus muscles, we found that DAG levels were increased, and PKC was translocated, in soleus muscles of both (1) normoglycemic hyperinsulinemic obese/aged rats and (2) mildly hyperglycemic hyperinsulinemic obese/Zucker rats. In keeping with the possibility that PKC activation may contribute to impaired glycogen synthase activation in GK muscles, phorbol esters inhibited, and a PKC inhibitor, RO 31-8220, increased insulin effects on glycogen synthesis in soleus muscles incubated in vitro. Our findings suggested that: (1) hyperinsulinemia, as observed in type II diabetic GK rats and certain genetic and nongenetic forms of obesity in rats, is associated with persistent translocation and activation of PKC in soleus muscles, and (2) this persistent PKC activation may contribute to impaired glycogen synthesis and insulin resistance.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Z. Gao, Z. Wang, X. Zhang, A. A. Butler, A. Zuberi, B. Gawronska-Kozak, M. Lefevre, D. York, E. Ravussin, H.-R. Berthoud, et al. Inactivation of PKC{theta} leads to increased susceptibility to obesity and dietary insulin resistance in mice Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E84 - E91. [Abstract] [Full Text] [PDF]

				K. Mussig, H. Staiger, H. Fiedler, K. Moeschel, A. Beck, M. Kellerer, and H.-U. Haring Shp2 Is Required for Protein Kinase C-dependent Phosphorylation of Serine 307 in Insulin Receptor Substrate-1 J. Biol. Chem., September 23, 2005; 280(38): 32693 - 32699. [Abstract] [Full Text] [PDF]

				S. R. Kashyap, R. Belfort, R. Berria, S. Suraamornkul, T. Pratipranawatr, J. Finlayson, A. Barrentine, M. Bajaj, L. Mandarino, R. DeFronzo, et al. Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E537 - E546. [Abstract] [Full Text] [PDF]

				E. Rodriguez, N. Pulido, R. Romero, F. Arrieta, A. Panadero, and A. Rovira Phosphatidylinositol 3-Kinase Activation Is Required for Sulfonylurea Stimulation of Glucose Transport in Rat Skeletal Muscle Endocrinology, February 1, 2004; 145(2): 679 - 685. [Abstract] [Full Text] [PDF]

				M. C. Sugden and M. J. Holness Potential Role of Peroxisome Proliferator-Activated Receptor-{alpha} in the Modulation of Glucose-Stimulated Insulin Secretion Diabetes, February 1, 2004; 53(90001): S71 - 81. [Abstract] [Full Text]

				C. A. Haber, T. K. T. Lam, Z. Yu, N. Gupta, T. Goh, E. Bogdanovic, A. Giacca, and I. G. Fantus N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E744 - E753. [Abstract] [Full Text] [PDF]

				Y. Akimoto, H. Kawakami, K. Yamamoto, E. Munetomo, T. Hida, and H. Hirano Elevated Expression of O-GlcNAc-Modified Proteins and O-GlcNAc Transferase in Corneas of Diabetic Goto-Kakizaki Rats Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 3802 - 3809. [Abstract] [Full Text] [PDF]

				C. Lindschau, P. Quass, J. Menne, F. Guler, A. Fiebeler, M. Leitges, F. C. Luft, and H. Haller Glucose-Induced TGF-{beta}1 and TGF-{beta} Receptor-1 Expression in Vascular Smooth Muscle Cells Is Mediated by Protein Kinase C-{alpha} Hypertension, September 1, 2003; 42(3): 335 - 341. [Abstract] [Full Text] [PDF]

				K. Hojlund, P. Staehr, B. F. Hansen, K. A. Green, D. G. Hardie, E. A. Richter, H. Beck-Nielsen, and J. F.P. Wojtaszewski Increased Phosphorylation of Skeletal Muscle Glycogen Synthase at NH2-Terminal Sites During Physiological Hyperinsulinemia in Type 2 Diabetes Diabetes, June 1, 2003; 52(6): 1393 - 1402. [Abstract] [Full Text] [PDF]

				Y. Lin, M. J. Brady, K. Wolanske, R. Holbert, N. B. Ruderman, and G. C. Yaney Alterations of nPKC distribution, but normal Akt/PKB activation in denervated rat soleus muscle Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E318 - E325. [Abstract] [Full Text] [PDF]

				R. V. Farese Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E1 - E11. [Abstract] [Full Text] [PDF]

				L. M. Gronning, A. Cederberg, N. Miura, S. Enerback, and K. Tasken Insulin and TNF{alpha} Induce Expression of the Forkhead Transcription Factor Gene Foxc2 in 3T3-L1 Adipocytes via PI3K and ERK 1/2-Dependent Pathways Mol. Endocrinol., April 1, 2002; 16(4): 873 - 883. [Abstract] [Full Text] [PDF]

				T. Pratipanawatr, K. Cusi, P. Ngo, W. Pratipanawatr, L. J. Mandarino, and R. A. DeFronzo Normalization of Plasma Glucose Concentration by Insulin Therapy Improves Insulin-Stimulated Glycogen Synthesis in Type 2 Diabetes Diabetes, February 1, 2002; 51(2): 462 - 468. [Abstract] [Full Text] [PDF]

				A. M. Efanov, I. B. Appelskog, S. M. Abdel-Halim, A. Khan, R. Branstrom, O. Larsson, C.-G. Ostenson, H.-J. Mest, P.-O. Berggren, S. Efendic, et al. Insulinotropic activity of the imidazoline derivative RX871024 in the diabetic GK rat Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E117 - E124. [Abstract] [Full Text] [PDF]

				Y. Lin, S. I. Itani, T. G. Kurowski, D. J. Dean, Z. Luo, G. C. Yaney, and N. B. Ruderman Inhibition of insulin signaling and glycogen synthesis by phorbol dibutyrate in rat skeletal muscle Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E8 - E15. [Abstract] [Full Text] [PDF]

				Y. Kanoh, G. Bandyopadhyay, M. P. Sajan, M. L. Standaert, and R. V. Farese Rosiglitazone, Insulin Treatment, and Fasting Correct Defective Activation of Protein Kinase C-{{zeta}}/{{lambda}} by Insulin in Vastus Lateralis Muscles and Adipocytes of Diabetic Rats Endocrinology, April 1, 2001; 142(4): 1595 - 1605. [Abstract] [Full Text]

				Y. Ikeda, G. S. Olsen, E. Ziv, L. L. Hansen, A. K. Busch, B. F. Hansen, E. Shafrir, and L. Mosthaf-Seedorf Cellular Mechanism of Nutritionally Induced Insulin Resistance in Psammomys Obesus: Overexpression of Protein Kinase C{varepsilon} in Skeletal Muscle Precedes the Onset of Hyperinsulinemia and Hyperglycemia Diabetes, March 1, 2001; 50(3): 584 - 592. [Abstract] [Full Text]

				E. Montell, M. Turini, M. Marotta, M. Roberts, V. Noe, C. J. Ciudad, K. Mace, and A. M. Gomez-Foix DAG accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E229 - E237. [Abstract] [Full Text] [PDF]

				K. S. Bell, C. Schmitz-Peiffer, M. Lim-Fraser, T. J. Biden, G. J. Cooney, and E. W. Kraegen Acute reversal of lipid-induced muscle insulin resistance is associated with rapid alteration in PKC-theta localization Am J Physiol Endocrinol Metab, November 1, 2000; 279(5): E1196 - E1201. [Abstract] [Full Text] [PDF]

				C. E. Chalfant, T. P. Ciaraldi, J. E. Watson, S. Nikoulina, R. R. Henry, and D. R. Cooper Protein Kinase C{theta} Expression Is Increased upon Differentiation of Human Skeletal Muscle Cells: Dysregulation in Type 2 Diabetic Patients and a Possible Role for Protein Kinase C{theta} in Insulin-Stimulated Glycogen Synthase Activity Endocrinology, August 1, 2000; 141(8): 2773 - 2778. [Abstract] [Full Text] [PDF]

				R. N. Cortright, J. L. Azevedo Jr., Q. Zhou, M. Sinha, W. J. Pories, S. I. Itani, and G. L. Dohm Protein kinase C modulates insulin action in human skeletal muscle Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E553 - E562. [Abstract] [Full Text] [PDF]

				D. R. Laybutt, C. Schmitz-Peiffer, A. K. Saha, N. B. Ruderman, T. J. Biden, and E. W. Kraegen Muscle lipid accumulation and protein kinase C activation in the insulin-resistant chronically glucose-infused rat Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E1070 - E1076. [Abstract] [Full Text] [PDF]

				M. L. Standaert, G. Bandyopadhyay, E. K. Antwi, and R. V. Farese RO 31-8220 Activates c-Jun N-Terminal Kinase and Glycogen Synthase in Rat Adipocytes and L6 Myotubes. Comparison to Actions of Insulin Endocrinology, May 1, 1999; 140(5): 2145 - 2151. [Abstract] [Full Text]

				G. Ranganathan, R. Kaakaji, and P. A. Kern Role of Protein Kinase C in the Translational Regulation of Lipoprotein Lipase in Adipocytes J. Biol. Chem., March 26, 1999; 274(13): 9122 - 9127. [Abstract] [Full Text] [PDF]

				N. B. Ruderman, A. K. Saha, D. Vavvas, and L. A. Witters Malonyl-CoA, fuel sensing, and insulin resistance Am J Physiol Endocrinol Metab, January 1, 1999; 276(1): E1 - E18. [Abstract] [Full Text] [PDF]

				P. J. Antoine, F. Bertrand, M. Auclair, J. Magre, J. Capeau, and G. Cherqui Insulin Induction of Protein Kinase C{alpha} Expression Is Independent of Insulin Receptor Tyr1162/1163 Residues and Involves Mitogen-Activated Protein Kinase Kinase 1 and Sustained Activation of Nuclear p44MAPK Endocrinology, July 1, 1998; 139(7): 3133 - 3142. [Abstract] [Full Text] [PDF]

				N. Meller, A. Altman, and N. Isakov New Perspectives on PKC{theta}, a Member of the Novel Subfamily of Protein Kinase C Stem Cells, May 1, 1998; 16(3): 178 - 192. [Abstract] [Full Text]

				C. Schmitz-Peiffer, N. D. Oakes, C. L. Browne, E. W. Kraegen, and T. J. Biden Reversal of chronic alterations of skeletal muscle protein kinase C from fat-fed rats by BRL-49653 Am J Physiol Endocrinol Metab, November 1, 1997; 273(5): E915 - E921. [Abstract] [Full Text] [PDF]

				Z. Liu, G.-Q. Chang, and S. F. Leibowitz Diacylglycerol Kinase zeta in Hypothalamus Interacts with Long Form Leptin Receptor. RELATION TO DIETARY FAT AND BODY WEIGHT REGULATION J. Biol. Chem., February 16, 2001; 276(8): 5900 - 5907. [Abstract] [Full Text] [PDF]